Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2200228	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2022-09-15	Tonghua Dongbao Pharmaceutical Co Ltd	view
CYSB2400166	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	Supplementary Application	2024-07-02	Yichang HEC Changjiang Pharmaceutical Co Ltd	view
CXSL2200053	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	New Drug Application	2022-01-27	Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd	view
CYSB2300089	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(原15)	Supplementary Application	2023-04-27	Zhejiang Hisun Pharmaceutical Co Ltd	view
CXSL2101313	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	New Drug Application	2021-09-08	ChongQing Chenan Biopharmaceutical Co Ltd	view
CXSL2400058	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	New Drug Application	2024-01-25	Jiangsu Hengrui Pharmaceuticals Co Ltd	view
CYSB2101304	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CYSB2101177	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-09-06	Gan & Lee Pharmaceuticals	view
CYSB2400073	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2024-03-18	Gan & Lee Pharmaceuticals	view
JXSB2200029	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2022-03-17	Novo Nordisk A/S	view
CYSB2300084	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2023-04-19	Gan & Lee Pharmaceuticals	view
CXSL2200051	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	New Drug Application	2022-01-27	Ningbo Kunpeng BIOTECH Co Ltd	view
CYSB2200235	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2022-09-28	Tonghua Dongbao Pharmaceutical Co Ltd	view
JYSB2101210	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23	Novo Nordisk A/S	view
CXSS2200008	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	New Drug Application	2022-01-28	Jilin Huisheng Biopharmaceutical Co Ltd	view
CYSB2101305	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CXSL2300177	门冬胰岛素注射液	insulin aspart	Injection	Biological Products(3.3)	New Drug Application	2023-03-08	Nanjing Han Xin Pharmaceutical Technology Co Ltd	view
CYSB2200229	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2022-09-15	Tonghua Dongbao Pharmaceutical Co Ltd	view
JYSB2101211	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-12-23	Novo Nordisk A/S	view
CYSB2400282	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2024-10-26	Gan & Lee Pharmaceuticals	view